Capturing HF observations during media fills and line simulations

Capturing HF Observations During Media Fills and Line Simulations Capturing HF Observations During Media Fills and Line Simulations This comprehensive regulatory explainer manual delves into the critical aspects of human factors (HF) simulations, particularly focusing on media fills and aseptic line simulations. Understanding the role of human factors in these scenarios is essential for regulatory affairs (RA), quality assurance (QA), quality control (QC), and validation professionals in the pharmaceutical and medical device industries. This article aligns with the regulatory frameworks and guidelines of the FDA, EMA, and MHRA, providing a structured overview to assist professionals in enhancing their regulatory compliance…

Continue Reading... Capturing HF observations during media fills and line simulations

Using video review to analyse operator actions in simulations

Using video review to analyse operator actions in simulations Using Video Review to Analyse Operator Actions in Simulations Human factors and operator qualification are critical components in the validation of processes within the pharmaceutical and biotechnology industries. The significance of evaluating operator behaviour in human factors simulation is underscored by regulatory frameworks globally. This article aims to provide a comprehensive regulatory explainer manual focused on utilizing video review in simulations, including mock runs and media fills, to analyse and enhance operator actions. Regulatory Context The incorporation of human factors principles into the development and validation of pharmaceutical processes is guided…

Continue Reading... Using video review to analyse operator actions in simulations

Regulatory expectations for simulation data in human factors programs

Regulatory expectations for simulation data in human factors programs Regulatory Expectations for Simulation Data in Human Factors Programs In the ever-evolving landscape of pharmaceutical and biotech manufacturing, the emphasis on human factors and operator qualification is increasingly critical. Regulatory authorities such as the FDA, EMA, and MHRA are mandating robust human factors programs that include rigorous simulation methods to enhance operator performance and reduce potential errors. This regulatory explainer manual provides a detailed overview of the expectations surrounding human factors simulation, focusing on essential components such as mock runs, media fills, scenario-based training, and aseptic line simulation. Understanding the Regulatory…

Continue Reading... Regulatory expectations for simulation data in human factors programs

Integrating mock runs into qualification and requalification plans

Integrating Mock Runs into Qualification and Requalification Plans Integrating Mock Runs into Qualification and Requalification Plans The integration of human factors simulation, including mock runs and media fills, is essential in the qualification and requalification plans in pharmaceuticals and medical devices. This article provides a comprehensive overview of the relevant regulatory expectations and provides practical insights into executing these simulations effectively within the bounds of regulatory frameworks in the US, UK, and EU. Context Human factors engineering (HFE) plays a pivotal role across the lifecycle of drug development and delivery systems. It focuses on understanding operator behavior and interaction with…

Continue Reading... Integrating mock runs into qualification and requalification plans

Lessons learned from simulation-based HF improvements in sterile plants

Lessons learned from simulation-based HF improvements in sterile plants Lessons learned from simulation-based HF improvements in sterile plants Context of Human Factors in Regulatory Affairs In the ever-evolving landscape of pharmaceutical and biotech industries, the significance of human factors (HF) cannot be understated. Human factors concern the interaction between operators and systems, particularly in sterile environments where any discrepancy can lead to catastrophic results. The integration of human factors simulation into validation protocols helps organizations mitigate risks associated with operator behavior, thereby ensuring product safety and compliance with regulatory standards. The US Food and Drug Administration (FDA), European Medicines Agency…

Continue Reading... Lessons learned from simulation-based HF improvements in sterile plants

Designing stress-test scenarios to expose human error vulnerabilities

Designing Stress-Test Scenarios to Expose Human Error Vulnerabilities Designing Stress-Test Scenarios to Expose Human Error Vulnerabilities This article serves as a comprehensive regulatory explainer manual focusing on the necessity and methodology for incorporating human factors simulation in validation processes. Within the realms of global regulatory affairs, understanding human factor regulations is essential for ensuring the integrity of pharmaceutical and medical device production. Regulatory Affairs Context In the context of pharmaceutical and biopharmaceutical manufacturing, the integration of Human Factors (HF) engineering is integral to ensuring that products are safe and effective for use. Human factors simulation plays a crucial role in…

Continue Reading... Designing stress-test scenarios to expose human error vulnerabilities

Using dry runs to de-risk new packaging and device assembly lines

Using dry runs to de-risk new packaging and device assembly lines Using Dry Runs to De-risk New Packaging and Device Assembly Lines Context In the highly regulated environments of pharmaceutical and medical device manufacturing, ensuring the efficacy and safety of products is paramount. Human factors simulation plays a critical role in this process, specifically through the use of dry runs, mock runs, and media fills. These techniques help to evaluate and mitigate risks associated with packaging and device assembly operations, addressing operator behavior and procedural adherence. Legal/Regulatory Basis In the United States, the FDA’s regulations found in 21 CFR Part…

Continue Reading... Using dry runs to de-risk new packaging and device assembly lines

Documenting simulation results in validation and HF files

Documenting Simulation Results in Validation and HF Files Documenting Simulation Results in Validation and HF Files In the realm of Regulatory Affairs (RA), particularly in the pharmaceutical and biotechnology industries, the documentation of human factors simulation results plays a crucial role in ensuring compliance with regulations and guidelines set forth by agencies such as the FDA, EMA, and MHRA. This article provides a structured guide for Kharma and regulatory professionals on the best practices for documenting simulation results, with a particular focus on validation and human factors (HF) files. Context of Human Factors Simulation in Validation The integration of human…

Continue Reading... Documenting simulation results in validation and HF files

Cross-functional participation in HF-focused mock runs and drills

Cross-functional participation in HF-focused mock runs and drills Cross-functional participation in HF-focused mock runs and drills Human Factors (HF) engineering is a critical element in the pharmaceutical and medical device industries, focusing on understanding how operators interact with systems to enhance safety and efficacy. This is particularly important in aseptic processes where operator behavior can influence the outcome of production. Mock runs, media fills, and simulation-based training are key tools for validating human factors in real-world scenarios. This article serves as a regulatory explainer manual, detailing the relevant regulations, guidelines, and expectations surrounding human factors simulation and cross-functional participation in…

Continue Reading... Cross-functional participation in HF-focused mock runs and drills

KPIs for simulation effectiveness and operator performance uplift

KPIs for Simulation Effectiveness and Operator Performance Uplift KPIs for Simulation Effectiveness and Operator Performance Uplift in Human Factors In the pharmaceutical and biotechnology sectors, ensuring operator competency is pivotal in maintaining quality and compliance. Human factors simulation plays a crucial role in validating processes that ensure safe and effective medicine production, particularly in aseptic environments. This article serves as a regulatory explainer manual designed for Kharma and regulatory professionals, focusing on key performance indicators (KPIs) for simulation effectiveness and operator performance uplift related to mock runs, media fills, and scenario-based training. Regulatory Context Human factors engineering (HFE) focuses on…

Continue Reading... KPIs for simulation effectiveness and operator performance uplift